Company Overview and News
Launched on 12/23/2014, the Invesco Russell 1000 Equal Weight ETF (EQAL - Free Report) is a passively managed exchange traded fund designed to provide a broad exposure to the Large Cap Blend segment of the US equity market.
LW IVV VST VSTE IVV MPC
2018-09-03 seekingalpha - 10
This article is part of a series that provides an ongoing analysis of the changes made to David Tepper’s 13F portfolio on a quarterly basis. It is based on Appaloosa Management’s regulatory 13F Form filed on 08/14/2018. Please visit our Tracking David Tepper’s Appaloosa Management Portfolio series to get an idea of his investment philosophy and our previous update for the fund’s moves during Q1 2018.
PCG LRCX SYMC KMT CQP CNC VST XOP KEY NRGEO CFIN WPZ BSX CIWV HCA SYK AABA AMAT WMB SUM BTUUQ VNTR BAC TMUSP LNG TMUS OC NRG ALL BABA ETP CZR GOOGL WMIH TERP WFCNP MGM FB PAH AY TMO WDC NVDA GOOG BAC HUN AGN UBS WFC WMIHP GJT XPO CFG BTU ALLY MU VSTE URI DG ULSGF
2018-09-02 seekingalpha - 4
This article is part of a series that provides an ongoing analysis of the changes made to John Paulson’s 13F stock portfolio on a quarterly basis. It is based on Paulson’s regulatory 13F Form filed on 08/14/2018. Please visit our Tracking John Paulson’s Paulson & Company Portfolio series to get an idea of his investment philosophy and our previous update for the fund’s moves during Q1 2018.
AKRX VST TWX AU ENL SHPG HAWK VIAB AABA DST OSG.WI AEM INSW MITL AGG SYMX AET FOX TMUSP TMUS RGORF BKD GOLD UTX 2840 TWC OGISD NSW OGSRW MDT SES CZR OGSWW OGISZ XLGLF QCOM INSW.WI FOXA OGSBW ENDP NMRK XL CTL RRS GLD AULGF OSG VRX ODP AGN EGN MON HZNP OSGB DISH OVSPW CMCSA CACQ COL GOLD OVSPA OVSPD VSTE THM BHS
EVANSVILLE, Ind., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Shareholders of Vectren Corporation (NYSE:VVC) today approved the merger of CenterPoint Energy and Vectren Corporation during a special shareholders meeting held to conduct a vote on matters relating to the proposed merger. The proposal to approve the merger was supported by 61.6 percent of Vectren Corporation’s outstanding common shares entitled to vote, or more than 95 percent of the shares voted.
NRGEO VVC NRG VST VSTE THHHV CNP ENBL
Vistra Energy Corp. subsidiary Luminant said Friday it has filed for the suspension of operations of its waste coal facility in McAdoo, Penn., citing "uneconomic operations and negative financial outlook." The company estimates that less than 25 full-time jobs will be lost by the closing of the facility. Luminant expects the plant to close in late 2018. Vistra's stock edged up 0.1% in morning trade.
2018-08-15 seekingalpha - 1
The portfolio is very concentrated with St. Joe Companies, Vista Outdoor, and Sears Holdings forming almost ~80% of the entire portfolio.
VST OAK FNMA SHLD IPMLF III CGBBW SHLDW FMCKI FMCKJ LUK FOCIX FMCCO FMCCP C FMCCM FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK VSTO FMCKL FAAFX SRG FMCC FAIRX VSTE FMCCS FMCCT
Ericsson (ERIC - Free Report) recently announced that it will add around 300 jobs in the United States. The company’s decision was backed by its motive to cater to the increasing demand for next-generation 5G equipment. Notably, the move is part of the rise in the company’s research and development investment.
TDS FOX VST ATP VSTE AT LMHA LMHB FOXA LM APRWF
2018-08-06 seekingalpha - 1
Good morning. My name is Tim and I will be your conference operator today. At this time, I would like to welcome everyone to the Vistra Energy Second Quarter 2018 Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions]
Vistra Energy Corp. (VST - Free Report) just came out with quarterly earnings of $0.20 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.01 per share a year ago. These figures are adjusted for non-recurring items.
VST VSTE EFR UUUU BGSF FUN
2018-07-16 zacks - 1
Investors with an interest in Utility - Electric Power stocks have likely encountered both Pattern Energy (PEGI - Free Report) and Vistra Energy Corp. (VST - Free Report) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
VST GTT VSTE
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
as of ET